PEPTIDE

AOD9604

AOD9604 is a 16-amino acid C-terminal fragment of human growth hormone (hGH residues 176–191). It selectively stimulates lipid metabolism research pathways and is studied in lipid metabolism models via β3-adrenergic receptor activation, without elevating IGF-1 or causing the systemic growth-related side effects of full-length hGH, making it a targeted peptide for fat metabolism research.

AOD9604 (Advanced Obesity Drug 9604) is a synthetic 16-amino acid peptide corresponding to the conserved C-terminal lipolytic domain (residues 176–191) of human growth hormone (hGH), optimized for targeted adipose tissue metabolism research:

Core Mechanism & Key Properties

Selectively activates β3-adrenergic receptors on adipocytes, stimulating hormone-sensitive lipase (HSL) to trigger breakdown of stored triglycerides into usable free fatty acids (lipolysis)
Inhibits de novo lipogenesis (new fat formation) by downregulating key lipogenic enzymes including acetyl-CoA carboxylase and fatty acid synthase
Critical distinction from full-length hGH: Does not bind to growth hormone receptors, does not elevate circulating IGF-1 levels, and does not produce the systemic anabolic, glycemic, or growth-related side effects of full hGH administration
Preferentially mobilizes visceral and stubborn abdominal adipose tissue in preclinical models

Primary Research Applications

Obesity and adipose tissue metabolism research
Targeted lipolysis and body composition modulation studies
Investigations of selective fat reduction without systemic growth hormone-related effects
Preclinical models of metabolic syndrome and visceral adiposity

Manufactured to ≥99% purity, sterile-filtered, and lyophilized for long-term storage stability.

For laboratory research use only; not intended for human or veterinary administration.

Research use only: This material is supplied for laboratory research and documentation workflows only. It is not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.

Hytan procurement and documentation support

For AOD9604, Hytan Peptides can support research-use sourcing review with available batch COA, vial labeling, product identity notes, storage documentation and wholesale quantity discussion. Product-specific CAS, sequence, molecular weight or method details should be confirmed against the current batch document before procurement decisions.

COA review: request batch-specific purity and identity references where available.
Wholesale planning: confirm vial strength, quantity, lead time, packing and destination requirements.
Compliance: research-use wording should remain clear in quote, invoice and receiving records.

Manufacturing Capability

Controlled production for consistent research peptide supply

Hytan Peptides supports wholesale research peptide orders with organized production workflow, clean handling, standardized filling, labeling and batch-level documentation. From material preparation to final review, each step is managed to support consistent appearance, traceable COA records and dependable supply coordination.

This production overview helps laboratories, distributors and qualified research buyers understand how Hytan Peptides approaches quality-focused peptide manufacturing, packaging and order readiness.